Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle VaccineJulio Carrera Montoya, Joseph Torresi, Kathryn C. Davidson et al.|Organoids|2024Cited by 12
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Joseph Torresi, Daniel Fernandez‐Ruiz et al.|npj Vaccines|2026Cited by 3
Preclinical evaluation of a cross-protective ß-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Joseph Torresi, William R. Heath, Linda Earnest et al.|Research Square|2024Cited by 2
Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59Linda Earnest, Joseph Torresi, Steven Rockman et al.|SSRN Electronic Journal|2024Cited by 0